Literature DB >> 18285330

Cholesterol, reactive oxygen species, and the formation of biologically active mediators.

Robert C Murphy1, Kyle M Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285330      PMCID: PMC2414298          DOI: 10.1074/jbc.R700049200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  46 in total

1.  Proatherogenic effects of the cholesterol ozonolysis products, atheronal-A and atheronal-B.

Authors:  Cindy Takeuchi; Roger Galvé; Jorgé Nieva; Daniel P Witter; Anita D Wentworth; Ryan P Troseth; Richard A Lerner; Paul Wentworth
Journal:  Biochemistry       Date:  2006-06-13       Impact factor: 3.162

2.  Comparative lipid analysis and structure of detergent-resistant membrane raft fractions isolated from human and ruminant erythrocytes.

Authors:  Kamen S Koumanov; Cedric Tessier; Albena B Momchilova; Dominique Rainteau; Claude Wolf; Peter J Quinn
Journal:  Arch Biochem Biophys       Date:  2005-02-01       Impact factor: 4.013

Review 3.  Membrane and protein interactions of oxysterols.

Authors:  John B Massey
Journal:  Curr Opin Lipidol       Date:  2006-06       Impact factor: 4.776

4.  Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols.

Authors:  S Lemaire-Ewing; C Prunet; T Montange; A Vejux; A Berthier; G Bessède; L Corcos; P Gambert; D Néel; G Lizard
Journal:  Cell Biol Toxicol       Date:  2005-03       Impact factor: 6.691

5.  Oxysterols increase in diabetic rats.

Authors:  Naoki Yoshioka; Junko Adachi; Yasuhiro Ueno; Ken-Ichi Yoshida
Journal:  Free Radic Res       Date:  2005-03

Review 6.  Lipid peroxidation: mechanisms, inhibition, and biological effects.

Authors:  Etsuo Niki; Yasukazu Yoshida; Yoshiro Saito; Noriko Noguchi
Journal:  Biochem Biophys Res Commun       Date:  2005-08-19       Impact factor: 3.575

Review 7.  Role of cholesterol and lipid organization in disease.

Authors:  Frederick R Maxfield; Ira Tabas
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

Review 8.  Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products.

Authors:  Gerhard Spiteller
Journal:  Free Radic Biol Med       Date:  2006-06-02       Impact factor: 7.376

9.  Protective effect of ebselen on cytotoxicity induced by cholestane-3 beta, 5 alpha, 6 beta-triol in ECV-304 cells.

Authors:  Qingzhi Wu; Kaixun Huang
Journal:  Biochim Biophys Acta       Date:  2006-03-20

10.  Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols.

Authors:  S L Hazen; F F Hsu; K Duffin; J W Heinecke
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

View more
  56 in total

1.  Surprising unreactivity of cholesterol-5,6-epoxides towards nucleophiles.

Authors:  Michael R Paillasse; Nathalie Saffon; Heinz Gornitzka; Sandrine Silvente-Poirot; Marc Poirot; Philippe de Medina
Journal:  J Lipid Res       Date:  2012-01-29       Impact factor: 5.922

2.  Unusual kinetic isotope effects of deuterium reinforced polyunsaturated fatty acids in tocopherol-mediated free radical chain oxidations.

Authors:  Connor R Lamberson; Libin Xu; Hubert Muchalski; J Rafael Montenegro-Burke; Vadim V Shmanai; Andrei V Bekish; John A McLean; Catherine F Clarke; Mikhail S Shchepinov; Ned A Porter
Journal:  J Am Chem Soc       Date:  2014-01-08       Impact factor: 15.419

3.  Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate.

Authors:  Raku Shinkyo; Libin Xu; Keri A Tallman; Qian Cheng; Ned A Porter; F Peter Guengerich
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

4.  Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Wei Liu; Lowell G Sheflin; Steven J Fliesler; Ned A Porter
Journal:  J Lipid Res       Date:  2011-08-04       Impact factor: 5.922

5.  Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease.

Authors:  Forbes D Porter; David E Scherrer; Michael H Lanier; S Joshua Langmade; Vasumathi Molugu; Sarah E Gale; Dana Olzeski; Rohini Sidhu; Dennis J Dietzen; Rao Fu; Christopher A Wassif; Nicole M Yanjanin; Steven P Marso; John House; Charles Vite; Jean E Schaffer; Daniel S Ory
Journal:  Sci Transl Med       Date:  2010-11-03       Impact factor: 17.956

Review 6.  Mitochondria as a target of cardioprotection in models of preconditioning.

Authors:  Magdaléna Jašová; Ivana Kancirová; Iveta Waczulíková; Miroslav Ferko
Journal:  J Bioenerg Biomembr       Date:  2017-07-20       Impact factor: 2.945

Review 7.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

8.  StarD4-mediated translocation of 7-hydroperoxycholesterol to isolated mitochondria: deleterious effects and implications for steroidogenesis under oxidative stress conditions.

Authors:  Witold Korytowski; Daniel Rodriguez-Agudo; Anna Pilat; Albert W Girotti
Journal:  Biochem Biophys Res Commun       Date:  2010-01-06       Impact factor: 3.575

9.  Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism.

Authors:  Sara Boenzi; Federica Deodato; Roberta Taurisano; Bianca Maria Goffredo; Cristiano Rizzo; Carlo Dionisi-Vici
Journal:  J Lipid Res       Date:  2016-01-05       Impact factor: 5.922

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.